Estimation of Serum SGOT

Introduction

  • AST stands for Aspartate Aminotransferase.
  • AST is also called SGOT (Serum Glutamate Oxaloacetate Transaminase).
  • It is an intracellular enzyme involved in amino acid metabolism.
  • AST belongs to the transferase group of enzymes.
  • It catalyzes transfer of amino group from aspartate to alpha-ketoglutarate.
  • This reaction forms oxaloacetate and glutamate.
  • AST is widely distributed in body tissues.
  • Highest concentration is found in heart, liver, skeletal muscle, kidney, and red blood cells.
  • Because AST is present in many tissues, it is less liver-specific than ALT.
  • AST estimation is commonly performed in liver function testing and cardiac enzyme studies.
  • Raised AST indicates tissue injury or cell damage.
  • AST is usually interpreted together with ALT for better diagnosis.
  • In liver disease, AST helps assess hepatocellular injury.
  • In muscle and cardiac disorders, AST may also rise significantly.

Principle

  • AST estimation is based on IFCC kinetic enzymatic method.
  • The reaction occurs in two stages.

Primary Reaction

  • AST catalyzes transfer of amino group from L-aspartate to 2-oxoglutarate.
  • Oxaloacetate and L-glutamate are produced.

Reaction

L-Aspartate + 2-Oxoglutarate → Oxaloacetate + L-Glutamate

Secondary Reaction

  • Oxaloacetate reacts with NADH in presence of Malate Dehydrogenase (MDH).
  • Oxaloacetate is reduced to malate.
  • NADH is oxidized to NAD⁺.

Reaction

Oxaloacetate + NADH → Malate + NAD⁺

Additional Reaction

  • LDH in reagent removes endogenous pyruvate interference.

Principle of Measurement

  • NADH absorbs ultraviolet light at 340 nm.
  • NAD⁺ does not absorb at this wavelength.
  • During reaction NADH decreases continuously.
  • This causes fall in absorbance.
  • Rate of absorbance decrease per minute is proportional to AST activity.

Specimen

Type of Sample

  • Serum is preferred specimen.
  • Plasma may also be used.
  • EDTA plasma is acceptable.
  • Heparinized plasma can also be used.

Precautions

  • Use non-hemolyzed serum only.
  • Hemolysis must be avoided because red blood cells contain high AST.
  • Hemolyzed sample gives falsely elevated result.

Sample Handling

  • Fresh sample preferred.
  • Separate serum early.
  • Avoid contamination.

Storage

  • Stable for 3 days at 2–8°C
  • Stable for several months at −20°C

Reagents

Reagent 1 (Buffer Reagent)

  • Tris buffer (pH 7.8)
  • L-aspartate
  • LDH enzyme
  • MDH enzyme

Reagent 2 (Substrate Reagent)

  • CAPSO
  • 2-oxoglutarate
  • NADH

Role of Reagents

  • Tris Buffer – Maintains optimal pH
  • L-Aspartate – Substrate for AST reaction
  • MDH – Catalyzes secondary reaction
  • LDH – Removes endogenous pyruvate interference
  • NADH – Indicator molecule for kinetic measurement

Materials Required

  • Test tubes
  • Micropipette
  • Pipette tips
  • Semi-auto analyzer
  • Spectrophotometer
  • Cuvette
  • Water bath
  • Timer
  • AST reagent kit

Procedure

Two Reagent Method

Components Quantity
Reagent 1 1000 µL
Sample 100 µL

First Incubation

  • Mix properly
  • Incubate at 37°C for 5 minutes

Then Add

Components Quantity
Reagent 2 250 µL

Second Incubation

  • Mix again
  • Incubate at 37°C for 1 minute

Reading

  • Read absorbance at 340 nm
  • Record absorbance at 1 minute, 2 minute, and 3 minute
  • Calculate average ΔA/min

Calculation

Formula

AST (U/L) = ΔA/min × Factor

Factor at 37°C and 340 nm

1745

Example

  • Absorbance at 1 minute = 0.700
  • Absorbance at 2 minute = 0.680
  • Absorbance at 3 minute = 0.660

ΔA/min

  • Difference = 0.020

Final Calculation

  • AST = 0.020 × 1745
  • AST = 34.9 U/L

Normal Reference Values

Group Normal Value
Men Up to 35 U/L
Women Up to 31 U/L

 


Clinical Significance 

  • AST is an important intracellular enzyme released into blood when cells are damaged.
  • Because AST is present in many tissues, an increased serum AST level indicates tissue injury but does not always specifically indicate liver disease.
  • The major tissues containing high AST activity are heart, liver, skeletal muscle, kidney, brain, and erythrocytes.
  • Therefore AST must always be interpreted together with clinical findings and other laboratory parameters.

Significance in Liver Disease

  • AST rises when hepatocytes are damaged and enzyme leaks into circulation.
  • In acute viral hepatitis, AST may increase several times above normal.
  • In severe hepatitis, values may rise 10 to 20 times normal level.
  • AST elevation often appears before jaundice develops.
  • In toxic hepatitis, AST rises rapidly because of sudden hepatocellular necrosis.
  • In drug-induced liver injury, AST may increase depending on severity of liver damage.
  • In cirrhosis, AST is usually moderately elevated because chronic destruction of liver cells occurs slowly.
  • In obstructive jaundice, AST may rise mildly to moderately.
  • In fatty liver disease, mild AST elevation is common.
  • In chronic hepatitis, persistent elevation suggests ongoing liver injury.
  • AST is usually less elevated than ALT in pure hepatocellular injury.

AST in Alcoholic Liver Disease

  • AST is particularly important in alcoholic liver disease.
  • In alcohol-induced liver injury, AST often becomes higher than ALT.
  • The AST/ALT ratio greater than 2 strongly suggests alcoholic hepatitis.
  • This occurs because alcohol damages mitochondrial AST-rich liver cells and reduces ALT synthesis.

AST in Myocardial Infarction

  • AST historically was one of the first cardiac enzymes used to diagnose myocardial infarction.
  • In acute myocardial infarction, AST begins to rise within 6–8 hours after chest pain.
  • Peak level occurs at 24–36 hours.
  • It returns to normal within 3–5 days.
  • Although troponin is now preferred, AST still indicates myocardial cell injury.
  • AST rise in cardiac disease occurs because damaged cardiac muscle releases intracellular enzyme.

AST in Skeletal Muscle Disease

  • Skeletal muscle contains large amounts of AST.
  • Muscle injury can produce significant AST elevation.
  • Increased AST occurs in:
  • muscular dystrophy
  • polymyositis
  • severe exercise
  • muscle trauma
  • intramuscular injections
  • crush injury
  • In muscle disorders, AST may rise without liver disease.

AST in Hemolysis

  • Red blood cells contain AST.
  • Hemolysis during sample collection can falsely elevate AST result.
  • Therefore non-hemolyzed serum is essential for correct interpretation.

AST in Kidney Disease

  • AST may rise in severe renal tissue injury.
  • Severe renal infarction can produce elevated AST.
  • Kidney disease alone usually causes only mild elevation.

AST in Pancreatic Disease

  • Acute pancreatitis may produce moderate AST increase.
  • This occurs due to associated tissue injury and inflammation.

AST in Shock and Hypoxia

  • Severe circulatory failure causes tissue hypoxia.
  • Hypoxia damages liver and muscle cells.
  • AST rises in shock because of generalized tissue injury.

AST in Burns and Trauma

  • Extensive burns release AST from damaged tissues.
  • Major trauma also causes AST elevation.
  • Higher values indicate greater tissue destruction.

Diagnostic Importance of AST with ALT

  • AST alone cannot identify exact organ source.
  • ALT is more liver specific.
  • Therefore AST is interpreted together with ALT.

Common Interpretation Pattern

AST > ALT

  • alcoholic liver disease
  • muscle injury
  • myocardial injury

ALT > AST

  • acute viral hepatitis
  • hepatocellular liver injury

AST/ALT Ratio Clinical Use

  • Ratio less than 1 usually suggests acute viral hepatitis.
  • Ratio greater than 2 suggests alcoholic liver disease.
  • Ratio near 1 may occur in chronic liver disease.

Prognostic Importance

  • Very high AST indicates severe tissue destruction.
  • Rapid fall after acute elevation may suggest recovery.
  • Persistent elevation indicates ongoing injury.

Clinical Use in Monitoring

  • Monitoring liver disease progression
  • Assessing treatment response
  • Detecting drug toxicity
  • Evaluating muscle disorders
  • Supporting diagnosis of cardiac injury

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
Enable Notifications OK No thanks